A Study to Evaluate the Safety, Tolerability and Efficacy of ILB in Patients With Amyotrophic Lateral Sclerosis
Clinical trial NCT03613571 · TERMINATED
Trial details
- NCT number
- NCT03613571
- Sponsor
- TikoMed AB
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-15
- Primary completion
- 2019-08-20
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.